EQS-Ad-hoc: European Healthcare Acquisition & Growth Company B.V. / Key word: Personnel
European Healthcare Acquisition & Growth Company B.V. announces change in CEO position
02-May-2024 /.
EQS-Adhoc: European Healthcare Acquisition & Growth Company B V : EHC announces change in CEO position finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
EQSAdhoc European Healthcare Acquisition & Growth Company BV Key word Personnel European Healthcare Acquisition & Growth Company BV announces change in CEO position 02May2024 0955 CETCEST Dis
EQS-Adhoc: European Healthcare Acquisition & Growth Company B V announces change in CEO position finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
December 9, 2020
Company announces $24 million Series A financing and appoints Jason T. Gammack as CEO to accelerate development and commercialization of Molecular Cartography
TM platform
MONHEIM AM RHEIN, Germany – Dec. 10, 2020 – Resolve Biosciences, the pioneer in Molecular Cartography™, today announced the completion of a $24 million Series A financing round and the appointment of Co-founder Jason T. Gammack as Chief Executive Officer.
The company s Molecular Cartography platform is a groundbreaking multi-analyte and highly multiplex spatial analysis technology that enables scientists to resolve the most daunting biological challenges in areas such as oncology, neuroscience, and infectious disease. It produces deep contextual data sets that illuminate molecular interactions at subcellular resolution, while preserving the sample tissue. The initial applications of Resolve s Molecular Cartography platform deliver the highest-resolution view of